Inequivalence of some Pharmaceuticals on the Kenyan Market

dc.contributor.author	Kibwage, IO
dc.contributor.author	Ondari, CO
dc.contributor.author	Ndemo, FA
dc.date.accessioned	2013-02-19T09:55:33Z
dc.date.issued	1988
dc.identifier.citation	Pharmaceutical journal of Kenya Vol 1 no.2	en
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10253
dc.description.abstract	An in vitro assessment of two types of products showed major deficiencies in formulation and manufacture. Some anUasthmatic syrups containing ephedrine, phenobarbitone and theophylline had evidence of preelpltatlon of phendbarbltone and theophylline. Other Investigations showed that products are marketed with declared active moiety different from that used in the manufacture. Properly conducted product development and adequately trained quality assurance personnel would alleviate such problems.	en
dc.language.iso	en	en
dc.title	Inequivalence of some Pharmaceuticals on the Kenyan Market	en
dc.type	Article	en